MedTrace Logo

Mixed Urinary Incontinence Symptoms Before and After Treatment With Botox and Bulkamid

NCT02815046 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2020-03-12

No results posted yet for this study

Summary

This study compares mixed urinary incontinence symptoms before and after a combined treatment with Botox and Bulkamid. Eligible for the study are adult females with a mixed urinary incontinence, having both urgency urinary symptoms and stress urinary symptoms.

Conditions

  • Mixed Incontinence, Urge and Stress

Interventions

DRUG

Botulinum toxin type A

Intravesical injections of Botulinum toxin A (Botox) into the bladder wall.

DEVICE

Polyacrylamide hydrogel

Midurethral injections of the bulking Agent Bulkamid into the submucosal tissues of the urethra.

Sponsors & Collaborators

  • Prof. Dr. Volker Viereck

    lead OTHER

Principal Investigators

  • Volker Viereck, MD · Cantonal Hospital, Frauenfeld

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02815046 on ClinicalTrials.gov